Finance

Beta
Lists
MRVI:NASDAQ
Maravai Lifesciences Holdings Inc
$5.02
+0.60%
(+0.030) 1D
$5.00
-0.40% (-0.020)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRVI...
Open
$4.99
High
$5.13
Low
$4.92
Mkt. cap
1.30B
Avg. vol.
2.71M
Volume
2.27M
52-wk high
$5.21
52-wk low
$1.99
EPS
-$0.72
Beta
0.72
Shares outstanding
147.51M
No. of employees
416
Open
$4.99
High
$5.13
Low
$4.92
Mkt. cap
1.30B
Avg. vol.
2.71M
Volume
2.27M
52-wk high
$5.21
52-wk low
$1.99
EPS
-$0.72
Beta
0.72
Shares outstanding
147.51M
No. of employees
416
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to MRVI in the past 3 months
Buy
Buy
3
Hold
2
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for MRVI in the last 3 months.
Highest
Current $5.02
$6.00 (+19.52%)
Average
$5.67 (+12.95%)
Lowest
$5.00 (-0.40%)
News stories
From sources across the web
About Maravai Lifesciences Holdings Inc
CEO-
Employees416
Founded2014
Headquarters-
SectorHealth care
Websitemaravai.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.01 / -$0.05
+121.02%beat
Revenue / Est. (USD)
65.84M / 53.19M
+23.79%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
47.40M
41.63M
49.87M
65.84M
Cost of goods sold
39.63M
35.98M
35.32M
32.14M
Cost of revenue
39.63M
35.98M
35.32M
32.14M
Research and development expenses
4.88M
3.84M
3.79M
3.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
38.58M
35.40M
30.38M
29.09M
Operating expense
43.46M
39.24M
34.17M
32.98M
Total operating expenses
83.09M
75.22M
69.50M
65.12M
Operating income
-35.69M
-33.58M
-19.63M
720.00K
Other non operating income
-4.06M
-71.00K
-43.00K
-494.00K
EBT including unusual items
-74.12M
-45.15M
-63.01M
-6.53M
EBT excluding unusual items
-43.54M
-37.70M
-23.84M
-3.65M
Income tax expense
-4.29M
-92.00K
6.00K
-151.00K
Effective tax rate
5.78%
0.20%
-0.01%
2.31%
Other operating expenses
-
-
-
-
Net income
-39.59M
-25.56M
-35.68M
-3.73M
Net profit margin
-83.53%
-61.39%
-71.55%
-5.67%
Earnings per share
-0.08
-0.08
-0.04
0.01
Interest and investment income
3.03M
2.80M
2.38M
1.87M
Interest expense
-6.82M
-6.84M
-6.56M
-5.75M
Net interest expenses
-3.78M
-4.05M
-4.17M
-3.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.53M
-20.40M
-7.18M
12.09M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer